{
  "DOI": "10.1186/s40246-023-00550-z",
  "ISSN": [
    "1479-7364"
  ],
  "URL": "http://dx.doi.org/10.1186/s40246-023-00550-z",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eBackground\u003c/jats:title\u003e\n                \u003cjats:p\u003eAccumulating observational studies have identified associations between type 1 diabetes (T1D) and polycystic ovary syndrome (PCOS). Still, the evidence about the causal effect of this association is uncertain.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eMethods\u003c/jats:title\u003e\n                \u003cjats:p\u003eWe performed a two-sample Mendelian randomization (MR) analysis to test for the causal association between T1D and PCOS using data from a large-scale biopsy-confirmed genome-wide association study (GWAS) in European ancestries. We innovatively divided T1D into nine subgroups to be analyzed separately, including: type1 diabetes wide definition, type1 diabetes early onset, type 1 diabetes with coma, type 1 diabetes with ketoacidosis, type 1 diabetes with neurological complications, type 1 diabetes with ophthalmic complications, type 1 diabetes with peripheral circulatory complications, type 1 diabetes with renal complications, and type 1 diabetes with other specified/multiple/unspecified complications. GWAS data for PCOS were obtained from a large-scale GWAS (10,074 cases and 103,164 controls) for primary analysis and the IEU consortium for replication and meta-analysis. Sensitivity analyses were conducted to evaluate heterogeneity and pleiotropy.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eResults\u003c/jats:title\u003e\n                \u003cjats:p\u003eFollowing rigorous instrument selection steps, the number of SNPs finally used for T1D nine subgroups varying from 6 to 36 was retained in MR estimation. However, we did not observe evidence of causal association between type 1 diabetes nine subgroups and PCOS using the IVW analysis, MR-Egger regression, and weighted median approaches, and all \u003cjats:italic\u003eP\u003c/jats:italic\u003e values were \u0026gt; 0.05 with ORs near 1. Subsequent replicates and meta-analyses also yielded consistent results. A number of sensitivity analyses also did not reveal heterogeneity and pleiotropy, including Cochran’s \u003cjats:italic\u003eQ\u003c/jats:italic\u003e test, MR-Egger intercept test, MR-PRESSO global test, leave-one-out analysis, and funnel plot analysis.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eConclusion\u003c/jats:title\u003e\n                \u003cjats:p\u003eThis is the first MR study to investigate the causal relationship between type 1 diabetes and PCOS. Our findings failed to find substantial causal effect of type 1 diabetes on risk of PCOS. Further randomized controlled studies and MR studies are necessary.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e",
  "alternative-id": [
    "550"
  ],
  "article-number": "100",
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "19 September 2023"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "7 November 2023"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "13 November 2023"
    },
    {
      "group": {
        "label": "Declarations",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Ethics approval and consent to participate",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "Only publicly available GWAS data were used in this study, and the Ethics approval and consent to participate could be available in the original GWAS study."
    },
    {
      "group": {
        "label": "Consent for publication",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "Not applicable."
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 4,
      "value": "The authors declare that they have no competing interests."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Chen",
      "given": "Shuwen",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Guo",
      "given": "Zaixin",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Yu",
      "given": "Qi",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genomics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2023,
        11,
        13
      ]
    ],
    "date-time": "2023-11-13T09:01:47Z",
    "timestamp": 1699866107000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        11,
        13
      ]
    ],
    "date-time": "2023-11-13T09:03:54Z",
    "timestamp": 1699866234000
  },
  "funder": [
    {
      "award": [
        "2022YFC2703802"
      ],
      "name": "National Key Research \u0026 Developmental Program of China"
    },
    {
      "award": [
        "2022-PUMCH-B-081"
      ],
      "name": "National High Level Hospital Clinical Research Funding"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2023,
        11,
        14
      ]
    ],
    "date-time": "2023-11-14T00:27:22Z",
    "timestamp": 1699921642754
  },
  "is-referenced-by-count": 0,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1479-7364"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2023,
        11,
        13
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-online": {
      "date-parts": [
        [
          2023,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2023,
            11,
            13
          ]
        ],
        "date-time": "2023-11-13T00:00:00Z",
        "timestamp": 1699833600000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2023,
            11,
            13
          ]
        ],
        "date-time": "2023-11-13T00:00:00Z",
        "timestamp": 1699833600000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-023-00550-z.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1186/s40246-023-00550-z/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-023-00550-z.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1186",
  "published": {
    "date-parts": [
      [
        2023,
        11,
        13
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2023,
        11,
        13
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "author": "M Asunción",
      "first-page": "2434",
      "journal-title": "J Clin Endocrinol Metab",
      "key": "550_CR1",
      "unstructured": "Asunción M, Calvo RM, San Millán JL, Sancho J, Avila S, Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab. 2000;85:2434–8.",
      "volume": "85",
      "year": "2000"
    },
    {
      "DOI": "10.1093/humrep/des028",
      "author": "R Sanchón",
      "doi-asserted-by": "publisher",
      "first-page": "1209",
      "journal-title": "Hum Reprod",
      "key": "550_CR2",
      "unstructured": "Sanchón R, Gambineri A, Alpañés M, Martínez-García MÁ, Pasquali R, Escobar-Morreale HF. Prevalence of functional disorders of androgen excess in unselected premenopausal women: a study in blood donors. Hum Reprod. 2012;27:1209–16.",
      "volume": "27",
      "year": "2012"
    },
    {
      "DOI": "10.1093/humrep/des232",
      "author": "BO Yildiz",
      "doi-asserted-by": "publisher",
      "first-page": "3067",
      "journal-title": "Hum Reprod",
      "key": "550_CR3",
      "unstructured": "Yildiz BO, Bozdag G, Yapici Z, Esinler I, Yarali H. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum Reprod. 2012;27:3067–73.",
      "volume": "27",
      "year": "2012"
    },
    {
      "DOI": "10.1210/jc.2009-2724",
      "author": "RA Wild",
      "doi-asserted-by": "publisher",
      "first-page": "2038",
      "journal-title": "J Clin Endocrinol Metab",
      "key": "550_CR4",
      "unstructured": "Wild RA, Carmina E, Diamanti-Kandarakis E, Dokras A, Escobar-Morreale HF, Futterweit W, Lobo R, Norman RJ, Talbott E, Dumesic DA. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the androgen excess and polycystic ovary syndrome (AE-PCOS) society. J Clin Endocrinol Metab. 2010;95:2038–49.",
      "volume": "95",
      "year": "2010"
    },
    {
      "key": "550_CR5",
      "unstructured": "Dolian GG, Burnazian RA, Vanetsian AL, Okoev GG, Abgarian MT (1989) Diagnostic criteria for polycystic ovary syndrome. Akush Ginekol (Mosk) 26–28"
    },
    {
      "DOI": "10.1093/humrep/deh098",
      "doi-asserted-by": "crossref",
      "key": "550_CR6",
      "unstructured": "Rotterdam ESHRE/ASRM‐Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum. Reprod. 19:41–47"
    },
    {
      "DOI": "10.1210/jc.2006-0178",
      "author": "R Azziz",
      "doi-asserted-by": "publisher",
      "first-page": "4237",
      "journal-title": "J Clin Endocrinol Metab",
      "key": "550_CR7",
      "unstructured": "Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE, et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab. 2006;91:4237–45.",
      "volume": "91",
      "year": "2006"
    },
    {
      "DOI": "10.1016/S0140-6736(13)60591-7",
      "author": "MA Atkinson",
      "doi-asserted-by": "publisher",
      "first-page": "69",
      "journal-title": "Lancet",
      "key": "550_CR8",
      "unstructured": "Atkinson MA, Eisenbarth GS, Michels AW. Type 1 diabetes. Lancet. 2014;383:69–82.",
      "volume": "383",
      "year": "2014"
    },
    {
      "DOI": "10.1203/01.PDR.0000059552.08913.B7",
      "author": "RA Heptulla",
      "doi-asserted-by": "publisher",
      "first-page": "830",
      "journal-title": "Pediatr Res",
      "key": "550_CR9",
      "unstructured": "Heptulla RA, Stewart A, Enocksson S, Rife F, Ma TY-Z, Sherwin RS, Tamborlane WV, Caprio S. In situ evidence that peripheral insulin resistance in adolescents with poorly controlled type 1 diabetes is associated with impaired suppression of lipolysis: a microdialysis study. Pediatr Res. 2003;53:830–5.",
      "volume": "53",
      "year": "2003"
    },
    {
      "DOI": "10.1210/jc.2002-021013",
      "author": "S Enoksson",
      "doi-asserted-by": "publisher",
      "first-page": "1503",
      "journal-title": "J Clin Endocrinol Metab",
      "key": "550_CR10",
      "unstructured": "Enoksson S, Caprio SK, Rife F, Shulman GI, Tamborlane WV, Sherwin RS. Defective activation of skeletal muscle and adipose tissue lipolysis in type 1 diabetes mellitus during hypoglycemia. J Clin Endocrinol Metab. 2003;88:1503–11.",
      "volume": "88",
      "year": "2003"
    },
    {
      "DOI": "10.1210/jc.2012-2892",
      "author": "BC Bergman",
      "doi-asserted-by": "publisher",
      "first-page": "E40",
      "journal-title": "J Clin Endocrinol Metab",
      "key": "550_CR11",
      "unstructured": "Bergman BC, Howard D, Schauer IE, Maahs DM, Snell-Bergeon JK, Clement TW, Eckel RH, Perreault L, Rewers M. The importance of palmitoleic acid to adipocyte insulin resistance and whole-body insulin sensitivity in type 1 diabetes. J Clin Endocrinol Metab. 2013;98:E40–50.",
      "volume": "98",
      "year": "2013"
    },
    {
      "DOI": "10.1210/er.2012-1053",
      "author": "H-S Moon",
      "doi-asserted-by": "publisher",
      "first-page": "377",
      "journal-title": "Endocr Rev",
      "key": "550_CR12",
      "unstructured": "Moon H-S, Dalamaga M, Kim S-Y, Polyzos SA, Hamnvik O-P, Magkos F, Paruthi J, Mantzoros CS. Leptin’s role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals. Endocr Rev. 2013;34:377–412.",
      "volume": "34",
      "year": "2013"
    },
    {
      "DOI": "10.1093/humupd/dms024",
      "author": "E Codner",
      "doi-asserted-by": "publisher",
      "first-page": "568",
      "journal-title": "Hum Reprod Update",
      "key": "550_CR13",
      "unstructured": "Codner E, Merino PM, Tena-Sempere M. Female reproduction and type 1 diabetes: from mechanisms to clinical findings. Hum Reprod Update. 2012;18:568–85.",
      "volume": "18",
      "year": "2012"
    },
    {
      "author": "HF Escobar-Morreale",
      "first-page": "4182",
      "journal-title": "J Clin Endocrinol Metab",
      "key": "550_CR14",
      "unstructured": "Escobar-Morreale HF, Roldán B, Barrio R, Alonso M, Sancho J, de la Calle H, García-Robles R. High prevalence of the polycystic ovary syndrome and hirsutism in women with type 1 diabetes mellitus. J Clin Endocrinol Metab. 2000;85:4182–7.",
      "volume": "85",
      "year": "2000"
    },
    {
      "DOI": "10.2337/diacare.24.7.1297",
      "author": "B Roldán",
      "doi-asserted-by": "publisher",
      "first-page": "1297",
      "journal-title": "Diabetes Care",
      "key": "550_CR15",
      "unstructured": "Roldán B, Escobar-Morreale HF, Barrio R, de La Calle H, Alonso M, García-Robles R, Sancho J. Identification of the source of androgen excess in hyperandrogenic type 1 diabetic patients. Diabetes Care. 2001;24:1297–9.",
      "volume": "24",
      "year": "2001"
    },
    {
      "DOI": "10.1111/pedi.12112",
      "author": "YH Cho",
      "doi-asserted-by": "publisher",
      "first-page": "18",
      "journal-title": "Pediatr Diabetes",
      "key": "550_CR16",
      "unstructured": "Cho YH, Craig ME, Donaghue KC. Puberty as an accelerator for diabetes complications. Pediatr Diabetes. 2014;15:18–26.",
      "volume": "15",
      "year": "2014"
    },
    {
      "DOI": "10.1210/clinem/dgab062",
      "author": "A Łebkowska",
      "doi-asserted-by": "publisher",
      "first-page": "1811",
      "journal-title": "J Clin Endocrinol Metab",
      "key": "550_CR17",
      "unstructured": "Łebkowska A, Adamska A, Krentowska A, Uruska A, Rogowicz-Frontczak A, Araszkiewicz A, Ożegowska K, Hryniewicka J, Leśniewska M, Wender-Ożegowska E, et al. The influence of prepubertal onset of type 1 diabetes and age of menarche on polycystic ovary syndrome diagnosis. J Clin Endocrinol Metab. 2021;106:1811–20.",
      "volume": "106",
      "year": "2021"
    },
    {
      "DOI": "10.2337/dc15-2577",
      "author": "HF Escobar-Morreale",
      "doi-asserted-by": "publisher",
      "first-page": "639",
      "journal-title": "Diabetes Care",
      "key": "550_CR18",
      "unstructured": "Escobar-Morreale HF, Roldán-Martín MB. Type 1 diabetes and polycystic ovary syndrome: systematic review and meta-analysis. Diabetes Care. 2016;39:639–48.",
      "volume": "39",
      "year": "2016"
    },
    {
      "DOI": "10.1093/ije/dyg070",
      "author": "GD Smith",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Int J Epidemiol",
      "key": "550_CR19",
      "unstructured": "Smith GD, Ebrahim S. “Mendelian randomization”: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol. 2003;32:1–22.",
      "volume": "32",
      "year": "2003"
    },
    {
      "DOI": "10.1002/gepi.21758",
      "author": "S Burgess",
      "doi-asserted-by": "publisher",
      "first-page": "658",
      "journal-title": "Genet Epidemiol",
      "key": "550_CR20",
      "unstructured": "Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37:658–65.",
      "volume": "37",
      "year": "2013"
    },
    {
      "DOI": "10.1038/s41586-022-05473-8",
      "author": "MI Kurki",
      "doi-asserted-by": "publisher",
      "first-page": "508",
      "journal-title": "Nature",
      "key": "550_CR21",
      "unstructured": "Kurki MI, Karjalainen J, Palta P, Sipilä TP, Kristiansson K, Donner KM, Reeve MP, Laivuori H, Aavikko M, Kaunisto MA, et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 2023;613:508–18.",
      "volume": "613",
      "year": "2023"
    },
    {
      "DOI": "10.1371/journal.pgen.1007813",
      "author": "F Day",
      "doi-asserted-by": "publisher",
      "first-page": "e1007813",
      "journal-title": "PLoS Genet",
      "key": "550_CR22",
      "unstructured": "Day F, Karaderi T, Jones MR, Meun C, He C, Drong A, Kraft P, Lin N, Huang H, Broer L, et al. Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria. PLoS Genet. 2018;14:e1007813.",
      "volume": "14",
      "year": "2018"
    },
    {
      "DOI": "10.1186/s13048-021-00879-w",
      "author": "H Chaudhary",
      "doi-asserted-by": "publisher",
      "first-page": "125",
      "journal-title": "J Ovarian Res",
      "key": "550_CR23",
      "unstructured": "Chaudhary H, Patel J, Jain NK, Joshi R. The role of polymorphism in various potential genes on polycystic ovary syndrome susceptibility and pathogenesis. J Ovarian Res. 2021;14:125.",
      "volume": "14",
      "year": "2021"
    },
    {
      "DOI": "10.1002/dmrr.3716",
      "doi-asserted-by": "crossref",
      "key": "550_CR24",
      "unstructured": "Onengut-Gumuscu S, Webb-Robertson B-JM, Sarkar S, Manichaikul A, Hu X, Frazer-Abel A, Holers VM, Rewers MJ, Rich SS. Genetic variants in the complement system and their potential link in the aetiology of type 1 diabetes. Diabetes/Metabolism Research and Reviews, 2023; e3716."
    },
    {
      "DOI": "10.2337/dc08-0239",
      "author": "S Fourlanos",
      "doi-asserted-by": "publisher",
      "first-page": "1546",
      "journal-title": "Diabetes Care",
      "key": "550_CR25",
      "unstructured": "Fourlanos S, Varney MD, Tait BD, Morahan G, Honeyman MC, Colman PG, Harrison LC. The rising incidence of type 1 diabetes is accounted for by cases with lower-risk human leukocyte antigen genotypes. Diabetes Care. 2008;31:1546–9.",
      "volume": "31",
      "year": "2008"
    },
    {
      "DOI": "10.2337/dc18-2023",
      "author": "M Zhu",
      "doi-asserted-by": "publisher",
      "first-page": "1414",
      "journal-title": "Diabetes Care",
      "key": "550_CR26",
      "unstructured": "Zhu M, Xu K, Chen Y, Gu Y, Zhang M, Luo F, Liu Y, Gu W, Hu J, Xu H, et al. Identification of novel T1D risk loci and their association with age and islet function at diagnosis in autoantibody-positive T1D individuals: based on a two-stage genome-wide association study. Diabetes Care. 2019;42:1414–21.",
      "volume": "42",
      "year": "2019"
    },
    {
      "DOI": "10.1371/journal.pone.0209830",
      "author": "U Branavan",
      "doi-asserted-by": "publisher",
      "first-page": "e0209830",
      "journal-title": "PLOS ONE",
      "key": "550_CR27",
      "unstructured": "Branavan U, Muneeswaran K, Wijesundera S, Jayakody S, Chandrasekharan V, Wijeyaratne C. Identification of selected genetic polymorphisms in polycystic ovary syndrome in Sri Lankan women using low cost genotyping techniques. PLOS ONE. 2018;13:e0209830.",
      "volume": "13",
      "year": "2018"
    },
    {
      "DOI": "10.1177/1933719118818899",
      "author": "K-L Hu",
      "doi-asserted-by": "publisher",
      "first-page": "1429",
      "journal-title": "Reprod Sci",
      "key": "550_CR28",
      "unstructured": "Hu K-L, Zhao H, Min Z, He Y, Li T, Zhen X, Ren Y, Chang H-M, Yu Y, Li R. Increased expression of KISS1 and KISS1 receptor in human granulosa lutein cells-potential pathogenesis of polycystic ovary syndrome. Reprod Sci. 2019;26:1429–38.",
      "volume": "26",
      "year": "2019"
    },
    {
      "DOI": "10.1186/s13048-023-01159-5",
      "author": "M Amin",
      "doi-asserted-by": "publisher",
      "first-page": "155",
      "journal-title": "J Ovarian Res",
      "key": "550_CR29",
      "unstructured": "Amin M, Horst N, Wu R, Gragnoli C. Novel corticotropin-releasing hormone receptor genes (CRHR1 and CRHR2) linkage to and association with polycystic ovary syndrome. J Ovarian Res. 2023;16:155.",
      "volume": "16",
      "year": "2023"
    },
    {
      "DOI": "10.1186/s13048-023-01205-2",
      "author": "M Amin",
      "doi-asserted-by": "publisher",
      "first-page": "158",
      "journal-title": "J Ovarian Res",
      "key": "550_CR30",
      "unstructured": "Amin M, Horst N, Gragnoli C. Linkage and association of variants in the dopamine receptor 2 gene (DRD2) with polycystic ovary syndrome. J Ovarian Res. 2023;16:158.",
      "volume": "16",
      "year": "2023"
    },
    {
      "DOI": "10.1093/humupd/dmac011",
      "author": "A Bayona",
      "doi-asserted-by": "publisher",
      "first-page": "501",
      "journal-title": "Hum Reprod Update",
      "key": "550_CR31",
      "unstructured": "Bayona A, Martínez-Vaello V, Zamora J, Nattero-Chávez L, Luque-Ramírez M, Escobar-Morreale HF. Prevalence of PCOS and related hyperandrogenic traits in premenopausal women with type 1 diabetes: a systematic review and meta-analysis. Hum Reprod Update. 2022;28:501–17.",
      "volume": "28",
      "year": "2022"
    },
    {
      "DOI": "10.1093/humrep/dey243",
      "author": "A Gunness",
      "doi-asserted-by": "publisher",
      "first-page": "1727",
      "journal-title": "Hum Reprod",
      "key": "550_CR32",
      "unstructured": "Gunness A, Pazderska A, Ahmed M, McGowan A, Phelan N, Boran G, Taylor AE, O’Reilly MW, Arlt W, Moore K, et al. Measurement of selected androgens using liquid chromatography-tandem mass spectrometry in reproductive-age women with Type 1 diabetes. Hum Reprod. 2018;33:1727–34.",
      "volume": "33",
      "year": "2018"
    },
    {
      "DOI": "10.1210/jc.2013-2669",
      "author": "MC Amato",
      "doi-asserted-by": "publisher",
      "first-page": "203",
      "journal-title": "J Clin Endocrinol Metab",
      "key": "550_CR33",
      "unstructured": "Amato MC, Guarnotta V, Ciresi A, Modica R, Pantò F, Giordano C. No phenotypic differences for polycystic ovary syndrome (PCOS) between women with and without type 1 diabetes mellitus. J Clin Endocrinol Metab. 2014;99:203–11.",
      "volume": "99",
      "year": "2014"
    },
    {
      "DOI": "10.1007/s40471-017-0128-6",
      "author": "J Zheng",
      "doi-asserted-by": "publisher",
      "first-page": "330",
      "journal-title": "Curr Epidemiol Rep",
      "key": "550_CR34",
      "unstructured": "Zheng J, Baird D, Borges M-C, Bowden J, Hemani G, Haycock P, Evans DM, Smith GD. Recent developments in mendelian randomization studies. Curr Epidemiol Rep. 2017;4:330–45.",
      "volume": "4",
      "year": "2017"
    },
    {
      "DOI": "10.1007/s00125-021-05571-8",
      "author": "A Green",
      "doi-asserted-by": "publisher",
      "first-page": "2741",
      "journal-title": "Diabetologia",
      "key": "550_CR35",
      "unstructured": "Green A, Hede SM, Patterson CC, Wild SH, Imperatore G, Roglic G, Beran D. Type 1 diabetes in 2017: global estimates of incident and prevalent cases in children and adults. Diabetologia. 2021;64:2741–50.",
      "volume": "64",
      "year": "2021"
    },
    {
      "DOI": "10.2337/dc21-1752",
      "author": "JL Harding",
      "doi-asserted-by": "publisher",
      "first-page": "994",
      "journal-title": "Diabetes Care",
      "key": "550_CR36",
      "unstructured": "Harding JL, Wander PL, Zhang X, Li X, Karuranga S, Chen H, Sun H, Xie Y, Oram RA, Magliano DJ, et al. The incidence of adult-onset Type 1 diabetes: a systematic review from 32 countries and regions. Diabetes Care. 2022;45:994–1006.",
      "volume": "45",
      "year": "2022"
    },
    {
      "DOI": "10.1089/jwh.2018.7162",
      "author": "E Carmina",
      "doi-asserted-by": "publisher",
      "first-page": "1385",
      "journal-title": "J Womens Health",
      "key": "550_CR37",
      "unstructured": "Carmina E, Lobo RA. Is there really increased cardiovascular morbidity in women with polycystic ovary syndrome? J Womens Health. 2018;27:1385–8.",
      "volume": "27",
      "year": "2018"
    },
    {
      "DOI": "10.2337/db20-0800",
      "author": "T Zhu",
      "doi-asserted-by": "publisher",
      "first-page": "627",
      "journal-title": "Diabetes",
      "key": "550_CR38",
      "unstructured": "Zhu T, Cui J, Goodarzi MO. Polycystic ovary syndrome and risk of type 2 diabetes, coronary heart disease, and stroke. Diabetes. 2021;70:627–37.",
      "volume": "70",
      "year": "2021"
    },
    {
      "DOI": "10.1210/er.2011-1034",
      "author": "E Diamanti-Kandarakis",
      "doi-asserted-by": "publisher",
      "first-page": "981",
      "journal-title": "Endocr Rev",
      "key": "550_CR39",
      "unstructured": "Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev. 2012;33:981–1030.",
      "volume": "33",
      "year": "2012"
    },
    {
      "DOI": "10.1038/nrendo.2018.24",
      "author": "HF Escobar-Morreale",
      "doi-asserted-by": "publisher",
      "first-page": "270",
      "journal-title": "Nat Rev Endocrinol",
      "key": "550_CR40",
      "unstructured": "Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018;14:270–84.",
      "volume": "14",
      "year": "2018"
    },
    {
      "DOI": "10.1530/EC-13-0089",
      "author": "PR van Dijk",
      "doi-asserted-by": "publisher",
      "first-page": "17",
      "journal-title": "Endocr Connect",
      "key": "550_CR41",
      "unstructured": "van Dijk PR, Logtenberg SJJ, Groenier KH, Kleefstra N, Bilo HJG, Arnqvist HJ. Effect of i.p. insulin administration on IGF1 and IGFBP1 in type 1 diabetes. Endocr Connect. 2014;3:17–23.",
      "volume": "3",
      "year": "2014"
    },
    {
      "DOI": "10.1016/j.ghir.2017.04.003",
      "author": "M Raisingani",
      "doi-asserted-by": "publisher",
      "first-page": "13",
      "journal-title": "Growth Horm IGF Res",
      "key": "550_CR42",
      "unstructured": "Raisingani M, Preneet B, Kohn B, Yakar S. Skeletal growth and bone mineral acquisition in type 1 diabetic children; abnormalities of the GH/IGF-1 axis. Growth Horm IGF Res. 2017;34:13–21.",
      "volume": "34",
      "year": "2017"
    },
    {
      "DOI": "10.1007/s00125-013-2904-2",
      "author": "SJ Cleland",
      "doi-asserted-by": "publisher",
      "first-page": "1462",
      "journal-title": "Diabetologia",
      "key": "550_CR43",
      "unstructured": "Cleland SJ, Fisher BM, Colhoun HM, Sattar N, Petrie JR. Insulin resistance in type 1 diabetes: What is “double diabetes” and what are the risks? Diabetologia. 2013;56:1462–70.",
      "volume": "56",
      "year": "2013"
    },
    {
      "DOI": "10.1016/j.jsbmb.2018.04.008",
      "author": "S Patel",
      "doi-asserted-by": "publisher",
      "first-page": "27",
      "journal-title": "J Steroid Biochem Mol Biol",
      "key": "550_CR44",
      "unstructured": "Patel S. Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy. J Steroid Biochem Mol Biol. 2018;182:27–36.",
      "volume": "182",
      "year": "2018"
    },
    {
      "DOI": "10.3390/ijms222413667",
      "author": "HA Schniewind",
      "doi-asserted-by": "publisher",
      "first-page": "13667",
      "journal-title": "Int J Mol Sci",
      "key": "550_CR45",
      "unstructured": "Schniewind HA, Sattler L-M, Haudum CW, Münzker J, Minich WB, Obermayer-Pietsch B, Schomburg L. Autoimmunity to the follicle-stimulating hormone receptor (FSHR) and luteinizing hormone receptor (LHR) in polycystic ovarian syndrome. Int J Mol Sci. 2021;22:13667.",
      "volume": "22",
      "year": "2021"
    },
    {
      "DOI": "10.1530/EC-18-0309",
      "author": "M Romitti",
      "doi-asserted-by": "publisher",
      "first-page": "1158",
      "journal-title": "Endocr Connect",
      "key": "550_CR46",
      "unstructured": "Romitti M, Fabris VC, Ziegelmann PK, Maia AL, Spritzer PM. Association between PCOS and autoimmune thyroid disease: a systematic review and meta-analysis. Endocr Connect. 2018;7:1158–67.",
      "volume": "7",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.autrev.2011.11.010",
      "author": "J Petríková",
      "doi-asserted-by": "publisher",
      "first-page": "A471",
      "journal-title": "Autoimmun Rev",
      "key": "550_CR47",
      "unstructured": "Petríková J, Lazúrová I. Ovarian failure and polycystic ovary syndrome. Autoimmun Rev. 2012;11:A471–8.",
      "volume": "11",
      "year": "2012"
    },
    {
      "DOI": "10.1016/S2213-8587(19)30345-6",
      "author": "EP Thong",
      "doi-asserted-by": "publisher",
      "first-page": "134",
      "journal-title": "Lancet Diabetes Endocrinol",
      "key": "550_CR48",
      "unstructured": "Thong EP, Codner E, Laven JSE, Teede H. Diabetes: a metabolic and reproductive disorder in women. Lancet Diabetes Endocrinol. 2020;8:134–49.",
      "volume": "8",
      "year": "2020"
    },
    {
      "DOI": "10.1093/ije/dyv071",
      "author": "AGC Boef",
      "doi-asserted-by": "publisher",
      "first-page": "496",
      "journal-title": "Int J Epidemiol",
      "key": "550_CR49",
      "unstructured": "Boef AGC, Dekkers OM, le Cessie S. Mendelian randomization studies: a review of the approaches used and the quality of reporting. Int J Epidemiol. 2015;44:496–511.",
      "volume": "44",
      "year": "2015"
    },
    {
      "DOI": "10.1001/jama.2017.17219",
      "author": "CA Emdin",
      "doi-asserted-by": "publisher",
      "first-page": "1925",
      "journal-title": "JAMA",
      "key": "550_CR50",
      "unstructured": "Emdin CA, Khera AV, Kathiresan S. Mendelian randomization. JAMA. 2017;318:1925–6.",
      "volume": "318",
      "year": "2017"
    },
    {
      "author": "E Carmina",
      "first-page": "1",
      "journal-title": "Minerva Ginecol",
      "key": "550_CR51",
      "unstructured": "Carmina E. Diagnosis of polycystic ovary syndrome: from NIH criteria to ESHRE-ASRM guidelines. Minerva Ginecol. 2004;56:1–6.",
      "volume": "56",
      "year": "2004"
    },
    {
      "DOI": "10.1038/ncomms9464",
      "author": "FR Day",
      "doi-asserted-by": "publisher",
      "first-page": "8464",
      "journal-title": "Nat Commun",
      "key": "550_CR52",
      "unstructured": "Day FR, Hinds DA, Tung JY, Stolk L, Styrkarsdottir U, Saxena R, Bjonnes A, Broer L, Dunger DB, Halldorsson BV, et al. Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome. Nat Commun. 2015;6:8464.",
      "volume": "6",
      "year": "2015"
    },
    {
      "DOI": "10.1007/s00392-021-01846-7",
      "author": "M Bahls",
      "doi-asserted-by": "publisher",
      "first-page": "1564",
      "journal-title": "Clin Res Cardiol",
      "key": "550_CR53",
      "unstructured": "Bahls M, Leitzmann MF, Karch A, Teumer A, Dörr M, Felix SB, Meisinger C, Baumeister SE, Baurecht H. Physical activity, sedentary behavior and risk of coronary artery disease, myocardial infarction and ischemic stroke: a two-sample Mendelian randomization study. Clin Res Cardiol. 2021;110:1564–73.",
      "volume": "110",
      "year": "2021"
    },
    {
      "DOI": "10.1111/add.15767",
      "author": "J Cai",
      "doi-asserted-by": "publisher",
      "first-page": "1382",
      "journal-title": "Addiction",
      "key": "550_CR54",
      "unstructured": "Cai J, He L, Wang H, Rong X, Chen M, Shen Q, Li X, Li M, Peng Y. Genetic liability for prescription opioid use and risk of cardiovascular diseases: a multivariable Mendelian randomization study. Addiction. 2022;117:1382–91.",
      "volume": "117",
      "year": "2022"
    },
    {
      "DOI": "10.1093/ije/dyy265",
      "author": "J Bowden",
      "doi-asserted-by": "publisher",
      "first-page": "2100",
      "journal-title": "Int. J. Epidemiol.",
      "key": "550_CR55",
      "unstructured": "Bowden J, Spiller W, Del Greco MF, Sheehan N, Thompson J, Minelli C, Davey Smith G. Improving the visualization, interpretation and analysis of two-sample summary data Mendelian randomization via the Radial plot and Radial regression. Int J Epidemiol. 2018;47:2100.",
      "volume": "47",
      "year": "2018"
    },
    {
      "DOI": "10.1002/gepi.21965",
      "author": "J Bowden",
      "doi-asserted-by": "publisher",
      "first-page": "304",
      "journal-title": "Genet Epidemiol",
      "key": "550_CR56",
      "unstructured": "Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40:304–14.",
      "volume": "40",
      "year": "2016"
    },
    {
      "DOI": "10.1093/ije/dyv080",
      "author": "J Bowden",
      "doi-asserted-by": "publisher",
      "first-page": "512",
      "journal-title": "Int J Epidemiol",
      "key": "550_CR57",
      "unstructured": "Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44:512–25.",
      "volume": "44",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.ebiom.2021.103592",
      "author": "X Chen",
      "doi-asserted-by": "publisher",
      "first-page": "103592",
      "journal-title": "EBioMedicine",
      "key": "550_CR58",
      "unstructured": "Chen X, Kong J, Pan J, Huang K, Zhou W, Diao X, Cai J, Zheng J, Yang X, Xie W, et al. Kidney damage causally affects the brain cortical structure: a Mendelian randomization study. EBioMedicine. 2021;72:103592.",
      "volume": "72",
      "year": "2021"
    },
    {
      "DOI": "10.1002/sim.6522",
      "author": "MFD Greco",
      "doi-asserted-by": "publisher",
      "first-page": "2926",
      "journal-title": "Stat Med",
      "key": "550_CR59",
      "unstructured": "Greco MFD, Minelli C, Sheehan NA, Thompson JR. Detecting pleiotropy in Mendelian randomisation studies with summary data and a continuous outcome. Stat Med. 2015;34:2926–40.",
      "volume": "34",
      "year": "2015"
    }
  ],
  "reference-count": 59,
  "references-count": 59,
  "resource": {
    "primary": {
      "URL": "https://humgenomics.biomedcentral.com/articles/10.1186/s40246-023-00550-z"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genomics"
  ],
  "source": "Crossref",
  "title": [
    "Genetic evidence for the causal association between type 1 diabetes and the risk of polycystic ovary syndrome"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "17"
}